Narrative review / 2014
Evidence indicates cannabis may act as a component cause in the emergence of psychosis and can exacerbate symptoms in established psychotic disorders.
This review evaluated case-studies, surveys, epidemiological studies, and experimental studies examining links between cannabis and psychosis or schizophrenia. Acute exposure to cannabis and synthetic cannabinoids can induce transient psychotomimetic symptoms, cognitive deficits, and psychophysiological abnormalities. In people with established psychotic disorders, cannabinoids can worsen symptoms and provoke relapse. The risk for later-life psychosis is dose-related and heightened by adolescent exposure, family history, childhood trauma, and COMT or AKT1 gene polymorphisms.
- Study type
- Narrative review
- Who was studied
- Individuals exposed to cannabis or cannabinoids
- What was measured
- Psychosis, psychotic disorders, and schizophrenia symptoms
THE PAPER
Gone to Pot - A Review of the Association between Cannabis and Psychosis.
Radhakrishnan R, Wilkinson ST, D'Souza DC. Front Psychiatry, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.